From microscopic mites dwelling in our hair follicles to sizable tapeworms inhabiting our intestines, the human body plays ...

YOUR skincare routine could be attracting microscopic creatures that have sex on your face, an expert has warned. Tiny mites, ...

Continuing to advance the pipeline and remain on-track to engage with the FDA on TP-04 (Papulopustular Rosacea) and TP-05 ...

About TP-04TP-04 is an aqueous gel formulation of lotilaner, a well-characterized anti-parasitic agent that paralyzes and kills mites by selectively inhibiting parasite-specific GABA-Cl channels.

particularly Demodex mites and certain bacteria like Staphylococcus epidermidis, are also implicated, as their presence may activate TLR2 and amplify AMP production. Additionally, increased expression ...

"Treatment with topical ivermectin may improve the symptoms of rosacea through modulation of the skin microbiome beyond decreasing Demodex," the authors concluded. "The results of this study ...

However, a leading eye expert has warned against sharing your sleeping space with man's best friend, as it could lead to a serious infestation of parasitic mites. Most people have a small population ...

Most people have a small population of demodex folliculorum - the 0.3mm long mites live in hair follicles on the face and nipples, eat sebum (the oily secretion produced by our bodies), and move ...

Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...

(RTTNews) - Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in collaboration with Dr. Reddy's ...

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.